
Biocon Biologics gets EU approval for Denosumab biosimilars
Denosumab biosimilars Vevzuo and Evfraxy are used for treating various bone diseases. The approvals mark a key step in the company’s European expansion and reinforce its commitment to affordable biologic therapies Published Date - 3 July 2025, 04:05 PM New …